Brief: InDex Pharmaceuticals Q4 EBIT SEK -107.9 Million
21/02/2024 07:00
Feb 21 (Reuters) - InDex Pharmaceuticals Q4 sales SEK 0. * Q4 adjusted EPS SEK -0.2 * Q4 cash flow from operating activities SEK -47 million * Q4 net income SEK -105.5 million
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen